Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Dolezal

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Folia Biologica|January 1, 1989
Computer-aided three-dimensional reconstructions of biological objects using simple facilitiesJ Spacek, T Dolezal, J Hanus, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Cost-Effectiveness Analysis of Bendamustin-Rituximab Compared to Chop-Rituximab in the Treatment of Indolent Follicular Non-Hodgkin Lymhoma in the Czech RepublicT Mlcoch, J Klimes, K Kruntoradova, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
The Impact of Adherence and Development of Neutralizing Antibodies to Interferons β on Treatment of Multiple Sclerosis in the Czech RepublicK Kruntoradova, J Klimes, T Dolezal, et al.
Physiological Research|July 22, 2008
Increased gene expression and production of spinal cyclooxygenase 1 and 2 during experimental osteoarthritis painM Prochazkova, P Zanvit, T Dolezal, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 4, 2011
Cost of multiple sclerosis in the Czech Republic: the COMS studyJ Blahova Dusankova, T Kalincik, T Dolezal, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Cost Effectiveness of Romiplostim for the Treatment of Immune Thrombocytopenia (Itp) Patients In the Czech RepublicT Brezina, J Klimes, T Dolezal, et al.
ESMO Open|July 6, 2023
Access to novel cancer medicines in four countries in Central and Eastern Europe in relation to clinical benefitT Hofmarcher, P Szilagyiova, A Gustafsson, et al.
Vnitrni Lekarstvi|May 3, 2007
[Guidelines for pharmacotherapy of acute and chronic non-oncological pain]T Dolezal, M Hakl, J Kozák, et al.
Vnitrni Lekarstvi|May 3, 2007
[Guidelines for pharmacotherapy of oncological pain]T Dolezal, M Hakl, J Kozák, et al.
Bone Marrow Transplantation|September 19, 2006
Clinical outcomes and direct hospital costs of reduced-intensity allogeneic transplantation in chronic myeloid leukemiaM Krejci, J Mayer, M Doubek, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Folia Biologica|January 1, 1989
Computer-aided three-dimensional reconstructions of biological objects using simple facilitiesJ Spacek, T Dolezal, J Hanus, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Cost-Effectiveness Analysis of Bendamustin-Rituximab Compared to Chop-Rituximab in the Treatment of Indolent Follicular Non-Hodgkin Lymhoma in the Czech RepublicT Mlcoch, J Klimes, K Kruntoradova, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
The Impact of Adherence and Development of Neutralizing Antibodies to Interferons β on Treatment of Multiple Sclerosis in the Czech RepublicK Kruntoradova, J Klimes, T Dolezal, et al.
Physiological Research|July 22, 2008
Increased gene expression and production of spinal cyclooxygenase 1 and 2 during experimental osteoarthritis painM Prochazkova, P Zanvit, T Dolezal, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 4, 2011
Cost of multiple sclerosis in the Czech Republic: the COMS studyJ Blahova Dusankova, T Kalincik, T Dolezal, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Cost Effectiveness of Romiplostim for the Treatment of Immune Thrombocytopenia (Itp) Patients In the Czech RepublicT Brezina, J Klimes, T Dolezal, et al.
ESMO Open|July 6, 2023
Access to novel cancer medicines in four countries in Central and Eastern Europe in relation to clinical benefitT Hofmarcher, P Szilagyiova, A Gustafsson, et al.
Vnitrni Lekarstvi|May 3, 2007
[Guidelines for pharmacotherapy of acute and chronic non-oncological pain]T Dolezal, M Hakl, J Kozák, et al.
Vnitrni Lekarstvi|May 3, 2007
[Guidelines for pharmacotherapy of oncological pain]T Dolezal, M Hakl, J Kozák, et al.
Bone Marrow Transplantation|September 19, 2006
Clinical outcomes and direct hospital costs of reduced-intensity allogeneic transplantation in chronic myeloid leukemiaM Krejci, J Mayer, M Doubek, et al.
Pageof 3